Optimizing investments in malaria treatment and diagnosis

Science

Volumn 338, Issue 6107, 2012, Pages 612-614

  Cohen, Justin M ^a   Woolsey, Aaron M ^a   Sabot, Oliver J ^a   Gething, Peter W ^b   Tatem, Andrew J ^c   Moonen, Bruno ^a  

^a CLINTON HEALTH ACCESS INITIATIVE   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; INSECTICIDE; ARTEMISIN; ARTEMISININ DERIVATIVE; LACTONE;

BED NET; DRUG EFFICACY; DRUG QUALITY; HEALTH CARE ACCESS; HEALTH CARE COST; HUMAN; INCIDENCE; INVESTMENT; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; MORTALITY; NONHUMAN; PLASMODIUM FALCIPARUM; PREVALENCE; PRIORITY JOURNAL; REVIEW; AFRICA SOUTH OF THE SAHARA; AGE; ARTICLE; CHILD; COST BENEFIT ANALYSIS; DRUG COMBINATION; ECONOMICS; FEVER; HEALTH CARE DELIVERY; HEALTH CARE POLICY; INTERNATIONAL COOPERATION; ORGANIZATION AND MANAGEMENT; PRESCHOOL CHILD; PUBLIC HEALTH; PUBLIC-PRIVATE PARTNERSHIP;

AFRICA SOUTH OF THE SAHARA; AGE FACTORS; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DRUG THERAPY, COMBINATION; FEVER; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTERNATIONAL COOPERATION; LACTONES; MALARIA; MALARIA, FALCIPARUM; PREVALENCE; PRIVATE SECTOR; PUBLIC HEALTH; PUBLIC-PRIVATE SECTOR PARTNERSHIPS;

EID: 84868255279     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1229045     Document Type: Review

References (24)

1. Roll Back Malaria Partnership, The Global Malaria Action Plan for a Malaria-Free World (Roll Back Malaria, Geneva, 2008).
2. WHO, World Malaria Report 2011 (WHO, Geneva, 2011).
3. K. A. O'Connell et al., Malar. J. 10, 326 (2011).
4. WHO, World Malaria Report 2010 (WHO, Geneva, 2010).
5. WHO, Guidelines for the Treatment of Malaria (WHO, Geneva, ed. 2, 2010).
6. B. A. Larson, A. A. Amin, A. M. Noor, D. Zurovac, R. W. Snow, BMC Public Health 6, 314 (2006).
7. G. M. L. Nayyar, J. G. Breman, P. N. Newton, J. Herrington, Lancet Infect. Dis. 12, 488 (2012).
8. F. Arnold et al., Preliminary Report of the Independent Evaluation of AMFm Phase 1 (ICF Macro and London School of Hygiene and Tropical Medicine, Calverton, MD, 2012).
9. Zanzibar Malaria Control Program, Malaria Elimination in Zanzibar: A Feasibility Assessment (Zanzibar Malaria Control Program, Stone Town, Zanzibar, 2009).
10. S. Kunene, A. A. Phillips, R. D. Gosling, D. Kandula, J. M. Novotny, Malar. J. 10, 313 (2011).
11. W. P. O'Meara, J. N. Mangeni, R. Steketee, B. Greenwood, Lancet Infect. Dis. 10, 545 (2010).
12. A. M. Dondorp et al., N. Engl. J. Med. 361, 455 (2009).
13. R. M. Fairhurst et al., Am. J. Trop. Med. Hyg. 87, 231 (2012).
14. Clinton Health Access Initiative, Evidence to Policy Initiative of the Global Health Group at the University of California San Francisco, and the African Leaders Malaria Alliance, Maintaining the Gains in Global Malaria Control (CHAI, E2Pi, ALMA, 2011).
15. S. Thiam et al., PLoS ONE 6, e18419 (2011).
16. G. J. Bastiaens et al., Malar. J. 10, 76 (2011).
17. V. D'Acremont, C. Lengeler, B. Genton, Malar. J. 9, 240 (2010).
18. T. Shewchuk et al., Malar. J. 10, 325 (2011).
19. G. Johnston, Repeated measures analysis with discrete data using the SAS system (SAS Institute Inc., Cary, NC, 1996); www2.sas.com/proceedings/sugi22/ STATS/PAPER278.PDF.
20. C. Linard, M. Gilbert, R. W. Snow, A. M. Noor, A. J. Tatem, PLoS ONE 7, e31743 (2012).
21. P. W. Gething et al., Malar. J. 10, 378 (2011).
22. E. A. Okiro, R. W. Snow, Malar. J. 9, 99 (2010).
23. D. L. Smith, C. A. Guerra, R. W. Snow, S. I. Hay, Malar. J. 6, 131 (2007).
24. D. M. Pigott, R. Atun, C. L. Moyes, S. I. Hay, P. W. Gething, Malar. J. 11, 246 (2012).